Back

Maintaining momentum: optimizing finerenone use in heart and kidney disease

10 May 2026 (12:35 - 12:50)
Organised by: Logo
Congress Presentation Part of: From evidence to action: a case-based guide to using finerenone in heart failure Chronic Heart Failure Open Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor John Ostrominski

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
Welcome and introductions
Professor B. Bozkurt (Houston, US)
Slides Video
Presentation thumbnail
The evolution of heart failure care: where are we in 2026?
Professor B. Bozkurt (Houston, US)
Slides Video
Presentation thumbnail
Leading the charge: getting started with finerenone in HF LVEF ≥40%
Doctor R. de la Espriella (Valencia, ES)
Slides Video
Presentation thumbnail
Audience Q&A and close
Professor B. Bozkurt (Houston, US)
Slides Video

Access the full session

Session thumbnail
From evidence to action: a case-based guide to using finerenone in heart failure
Video

The Event

Event poster

Heart Failure 2026

10 May 2026 12:35 CET
You may be interested in
thumbnail
Congress Session
From evidence to action: a case-based guide to using finerenone in heart failure
thumbnail
Congress Session
Non-steroidal mineralocorticoid receptor antagonists: current role and implementation in the management of patients with heart failure
thumbnail
Congress Presentation
Deep dive and Q&A: unraveling the differences between MRAs for the treatment of heart and kidney disease. Join a conversation discussing key evidence!

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources